Admission Date:  [**2188-6-5**]     Discharge Date:  [**2188-6-9**]  Date of Birth:   [**2129-2-10**]     Sex:  F  Service:  NEUROLOGY  HISTORY OF THE PRESENT ILLNESS:  The patient was a 59-year-old female with a past medical history of hypertension on medications who was last known to be well at 7:00 p.m. on [**2188-6-5**].
Given all of the clinical findings, the patient was given TPA with a 6.3 mg bolus and a set 56.7 mg IV drip over one hour.
She was given IV fluids for prophylaxis for DVT and GI prophylaxis as well.
PHYSICAL EXAMINATION:  Vital signs:  On examination, when the patient presented to the Emergency Room, the patient was afebrile at 97.9, blood pressure 155/63, pulse 65, respiratory rate 14, saturating at 100% on 1.5 liters nasal cannula.
The patient also had a gaze preference to the right with severe inattention on the left on subsequent examinations in the Intensive Care Unit.
Aspirin was held as per Stroke Team management as was heparin while the patient was in the ICU.
Repeat MRI of the head was performed in the ICU with resumption of Coumadin after the patient was cleared for any bleed on repeat MRI of the head.
The transesophageal echocardiogram did show a small PFO with a left-to-right shunt.
The patient also was very anxious during this admission and outpatient medications were continued with p.r.n.
The patient was continued on Celexa and Klonopin after psychiatry consultation.
The patient's physical examination and neurologic examination improved status post TPA administration and the patient had increased strength in the left upper extremity and lower extremity prior to discharge.
The patent foramen ovale was found on transesophageal echocardiogram.
Heparin IV was started.
The patient could leave on therapeutic Coumadin INR.
The patient then agreed to be discharged on Monday, [**2188-6-9**] with Coumadin follow-up for PFO and follow-up with Dr. [**Last Name (STitle) **] in the [**Hospital 878**] Clinic on [**2188-7-8**] and follow-up with primary care physician for INR [**Name9 (PRE) 702**] to keep between 2 and 2.5.
The patient was advised to consider Wellbutrin instead of Celexa to assist with smoking cessation to reduce risk factors for further stroke.
The patient then had follow-up with Dr. [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 105930**] for Coumadin monitoring on Wednesday, [**2188-6-11**], and finally follow-up with Dr. [**First Name (STitle) **] [**Name (STitle) **] on Thursday, [**2188-7-8**] at 1:00 p.m. in the [**Hospital 878**] Clinic in [**Hospital Ward Name 23**] office clinical center.
DIET:  The patient was advised to follow a 2 gram sodium diet with low-fat, low-cholesterol diet.
SERVICES:  The patient also had postdischarge services for teaching Lovenox administration and self-administration of Lovenox subcutaneously times three days.
Atorvostatin 10 mg p.o.
Warfarin 5 mg p.o.
Lovenox 5,000 unit q.
Klonopin 0.5 mg one tablet p.o.
Celexa 20 mg p.o.
Nicotine patch 24 hours transdermal, 40 mg per 24 hours.
The patient was told several times prior to discharge that continuation of lifestyle would precipitate further events such as ischemic stroke.
